BGT007 Cell Treatment of Nasopharyngeal Carcinoma

NCT05616468 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

BIOLOGICAL: BGT007 Cell Injection
DRUG: Fludarabine
DRUG: cyclophosphamide

Sponsor

The Affiliated Hospital of Xuzhou Medical University

Collaborators

[object Object]